Medtronic (NYSE:MDT) today announced new clinical findings supporting its Aurora EV-ICD system and OmniaSecure defibrillation ...

The global defibrillator market is highly competitive, dominated by established multinational manufacturers and a growing number of innovative technology-driven companies. In such an environment, ...

A team of researchers from Sergio Arboleda University in Bogotá, Colombia, and the Georgia Institute of Technology in Atlanta utilized an electrophysiological computer model of the heart’s electrical ...

The lead is designed to connect to an implantable defibrillator and claims to be the smallest in the world. Credit: Medtronic plc/PRNewswire. · Medical Device Network · Medtronic plc/PRNewswire. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Medtronic has secured FDA approval for its OmniaSecure defibrillation lead to be used in conduction system pacing, the first device cleared for left bundle branch area placement. The small, lumenless ...

The study, published in the New England Journal of Medicine on Nov. 24, studied patient outcomes for three methods of defibrillation: standard defibrillation; double sequential external defibrillation ...

A new observational study suggests the position in which responders initially place the two defibrillator pads on the body may make a significant difference in returning spontaneous blood circulation ...

An international team of scientists is on the cutting edge of a new treatment for cardiac arrhythmia that uses light beams instead of electricity to restore the heart’s healthy beat. The new method of ...

Traditional hospital factors -- such as case volume and academic status -- do not appear to predict whether patients with cardiac arrest at that facility are likely to experience delays in receiving ...